61
6
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10917 |
LTB4-IN-1
Anti-inflammatory agent 2 |
LTR | Immunology/Inflammation |
LTB4-IN-1 (Anti-inflammatory agent 2) 是白三烯 (LTB4) 合成抑制剂,IC50 为 70 nM。 | |||
T78678 | LTB4 antagonist 3 | Leukotriene Receptor | GPCR/G Protein |
LTB4 antagonist 3 (compound 24e)为一种具有抗炎活性的LTB4拮抗剂,其IC50为477 nM。 | |||
T78677 | LTB4 antagonist 2 | Leukotriene Receptor | GPCR/G Protein |
LTB4 antagonist 2为甲酰胺化合物,白三烯B4 (LTB4) 拮抗剂,显示抗炎潜能。该化合物对LTB4受体亲和力高,IC50值为439 nM。 | |||
T72625 | LTB4 antagonist 1 | Leukotriene Receptor | GPCR/G Protein |
LTB4 antagonist 1为甲酰胺化合物,高效拮抗白三烯B4 (LTB4),IC50值为288 nM,呈现出明显的抗炎活性。 | |||
T79389 |
LTB4-IN-2
|
FLAP | Immunology/Inflammation |
LTB4-IN-2(Compound 6x)是一种选择性的5-脂氧合酶激活蛋白(FLAP)抑制剂,旨在抑制白三烯B4(LTB4)的形成(IC50:1.15 μM),适用于抗炎研究。 | |||
T22946 |
LY255283
LY 255283 |
Leukotriene Receptor | GPCR/G Protein |
LY255283 是白三烯 B4 (LTB4) 受体的特异性拮抗剂,抑制人外周血多形核白细胞和由钙离子载体 A23187 激活的单核细胞中 LTB(4) 的产生。 | |||
T14045 |
Leukotriene B4
LTB4,5(S),12(R)-DiHETE |
Others | Others |
Leukotriene B4 is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | |||
T17191 |
Bunaprolast
U66858 |
Lipoxygenase; LTR | Immunology/Inflammation; Metabolism |
Bunaprolast (U66858) 是一种新型有效的白三烯 B4 (LTB4) 抑制剂。Bunaprolast 具有氧化降解活性,对脂氧合酶 (lipoxygenase)和 TXB2 释放具有抑制作用。 | |||
T15002 |
CP-105696
Pfizer 105696 |
LTR | Immunology/Inflammation |
CP-105696 是一种具有强效性和选择性白三烯 B4 (LTB4) 受体拮抗剂,可用于研究异体移植物排斥反应。 | |||
T11487 |
Fiboflapon
GSK2190915,AM-803 |
FLAP | Immunology/Inflammation |
Fiboflapon (GSK2190915) 是一种可口服且具有有效性 5-脂氧合酶激活蛋白 (FLAP) 抑制剂,结合 FLAP 的效价为 2.9 nM,对人血中 LTB4 有抑制作用, IC50 值为 76 nM。 | |||
T28974 |
Ticolubant
|
Calcium Channel; LTR | Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism |
Ticolubant 是一种具有口服活性的白三烯 B4 拮抗剂,对人类中性粒细胞 LTB4 受体具有很高的亲和力(Ki = 0.78 nM),能阻断 LTB4 诱导的 Ca2+ 迁移,IC50 为 6.6±1.5 nM,并在小鼠皮肤炎症模型中显示出局部抗炎活性。 | |||
T22358 |
Etalocib
LY293111,VML295 |
Apoptosis; Leukotriene Receptor; LTR | Apoptosis; GPCR/G Protein; Immunology/Inflammation |
Etalocib (LY293111) 是一种具有口服活性的白三烯(LTB4)受体的拮抗剂,抑制 [3H]LTB4结合的 Ki 值为 25 nM。它还可诱导凋亡。它抑制 LTB4诱导的钙动员,lC50值为 20 nM。 | |||
T10960L |
Darbufelone mesylate
CI-1004 mesylate |
Prostaglandin Receptor; LTR | GPCR/G Protein; Immunology/Inflammation |
Darbufelone mesylate (CI-1004 mesylate) 对细胞中 PGF2α 和 LTB4 产生有抑制作用。Darbufelone mesylate 对 PGHS-2 有抑制作用,IC50 值为 0.19 μM,对 PGHS-1 的IC50 值为 20 μM。 | |||
T9878 |
Croconazole
|
Lipoxygenase; LTR | Immunology/Inflammation; Metabolism |
Croconazole 对中性粒细胞的 5-脂氧合酶 (5-LOX) 表现出剂量依赖性抑制活性。Croconazole 是一种抗真菌剂。Croconazole 对合成白三烯 B4 (LTB4) 和 5-羟基二十碳四烯酸 (5-HETE) 的 IC50 分别为 7.8 ± 1.7 和 7.6 ± 0.3 μM。 | |||
T68155 |
Tebufelone
|
Prostaglandin Receptor; LTR | GPCR/G Protein; Immunology/Inflammation |
Tebufelone 是一种体外高效的CO 抑制剂 ,是一种新型的非甾体抗炎药(NSAID),属于二叔丁基苯酚(DTBP)类,在各种动物模型中显示出强大的抗炎、镇痛和抗网膜炎特性。Tebufelone 能有效地抑制前列腺素(PGE2)的形成,阻止大鼠巨噬细胞(IC50 = 20 microM)和人类全血(IC50 = 22 microM)中脂氧酶途径的产物[白三烯(LTB4)]的体外形成。 | |||
T10960 |
Darbufelone
达布非酮,CI-1004 |
Prostaglandin Receptor; LTR | GPCR/G Protein; Immunology/Inflammation |
Darbufelone (CI-1004) 是 PGF2α 和 LTB4 的非竞争性双重抑制剂。 Dabfilon 有效抑制 PGHS-2,对 PGHS-2 和 PGHS-1 的 Ki 为 10 μM,IC50 为 0.19 μM 和 20 μM。 | |||
T11699 |
J-113863
|
CCR | Immunology/Inflammation; Microbiology/Virology |
J-113863 是选择性的 CCR1 (CD18)拮抗剂,有抗炎作用,对人和小鼠 CCR1受体的 IC50值分别为 0.9 和 5.8 nM。它是人 CCR3的强效拮抗剂,还是小鼠 CCR3的弱效拮抗剂,IC50分别为 0.58 和 460 nM。 | |||
T16395 |
ONO4057
ONO-LB457 |
Leukotriene Receptor | GPCR/G Protein |
ONO4057 是一种具有有效性和口服活性的 Leukotriene B4 受体拮抗剂,其 IC50 值为 0.7±0.3 μM。 ONO4057 对大鼠同种异体移植的免疫抑制作用。 | |||
T15801 | LY210073 | Others | Others |
LY210073 is an antagonist of the Leukotriene B4 (LTB4) receptor (IC50: 6.2 nM). | |||
T10208 |
A-69412
N-1-(Fur-3-ylethyl)-N-hydroxyurea |
Lipoxygenase | Metabolism |
A-69412 (N-1-(Fur-3-ylethyl)-N-hydroxyurea) 是一种特异性的 5-脂氧合酶 (5-LO) 的可逆抑制剂。 A-69412 能用于哮喘和溃疡性结肠炎,以及其他炎症和过敏症状的研究。 | |||
T15803 |
LY223982
SKF107324,CGS23131 |
Others | Others |
LY223982 is an effective and specific inhibitor of the leukotriene B4 receptor (IC50: 13.2 nM). It also can against [3H]LTB4 binding to LTB4 receptor. | |||
T38087 |
20-hydroxy Leukotriene B4
20-hydroxy Leukotriene B4 |
||
20-hydroxy LTB4 is a metabolite of LTB4 in human neutrophils. In human leukocytes, LTB4 is inactivated by the enzyme LTB4 20-hydroxylase. 20-hydroxy LTB4 is not only much less active (~5%) compared to LTB4 in causing degranulation of PMNL, but actually inhibits LTB4-induced degranulation of human neutrophils (Ki = 13.3 nM). However, 20-hydroxy LTB4 is as active as LTB4 in contracting parenchymal strips from guinea pig lung. 20-hydroxy LTB4 retains considerable ligand binding affinity at the BLT2... | |||
T11487L |
Fiboflapon sodium
GSK2190915 sodium salt,AM-803 sodium |
LTR | Immunology/Inflammation |
Fiboflapon sodium (GSK2190915) is an orally bioavailable 5-lipoxygenase-activating protein (FLAP) inhibitor with a potency of 2.9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood. | |||
T1544 |
Olsalazine disodium
Dipentum,奥沙拉秦钠,Olsalazine Sodium |
Others; COX; Antibacterial; Antibiotic | Immunology/Inflammation; Microbiology/Virology; Neuroscience; Others |
Olsalazine disodium (Dipentum) 是抗炎化合物,可作用于溃疡性结肠炎和炎症性肠病。 | |||
T10543 |
BIIL-260 hydrochloride
|
Others | Others |
BIIL-260 hydrochloride is a potent and long-acting orally active antagonist of leukotriene B4 (LTB4) receptor with anti-inflammatory activity. It has a high affinity to the LTB4 receptor on isolated human neutrophil cell membranes (Ki: 1.7 nM). | |||
T14210 |
Amelubant
BIIL 284 |
LTR | Immunology/Inflammation |
Amelubant (BIIL 284) is a prodrug of active metabolites BIIL 260 and BIIL 315. Anti-inflammatory activity[1]. Amelubant (BIIL 284) is a potent, oral and long acting LTB4 receptor antagonist, negligibly binds to LTB4 receptor, with Kis of 221 nM and 230 nM | |||
T34555 |
SC 45694
SC45694,SC-45694 |
||
SC 45694 is a leukotriene B4 (LTB4) analog. | |||
T37619 |
Leukotriene B4 Ethanolamide
|
||
The effects of Leukotriene B4 (LTB4) are mediated by two known receptors, BLT1 and BLT2. LTB4 is a high affinity ligand for BLT1, and many of its pro-inflammatory effects are believed to be transduced through this receptor. The BLT2 is more enigmatic, in that LTB4 is not a high-affinity ligand, nor is it clear that BLT2 activation promotes inflammation. LTB4 ethanolamide (LTB4-EA) is a theoretical 5-LO metabolite of arachidonoyl ethanolamide (AEA). In CHO cells transfected with human BLTR1, LTB4... | |||
T37260 |
14,15-dehydro Leukotriene B4
14,15-dehydro Leukotriene B4 |
||
Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-lipoxygenase pathway. It promotes a number of leukocyte functions including aggregation, stimulation of ion fluxes, enhancement of lysosomal enzyme release, superoxide anion production, chemotaxis, and chemokinesis. At least two LTB4 receptors, termed BLT1 and BLT2, have been identified. 14,15-dehydro LTB4 is a LTB4 receptor antagonist that has a higher binding affinity for BLT1, demonstrating a Ki value ... | |||
T22526 |
BML-111
5(S),6(R)-7-trihydroxymethyl Heptanoate |
Others | Others |
inhibits leukotriene B4 (LTB4)-induced polymorphonuclear neutrophils (PMN) chemotaxis | |||
T73793 |
20-Carboxy-Leukotriene B4
|
||
20-Carboxy-Leukotriene B4 (20-COOH LTB4) 是 Leukotriene B4 (LTB4) 的代谢物。20-Carboxy-Leukotriene B4 以高亲和力与 BLT1 受体结合。20-Carboxy-Leukotriene B4 抑制 LTB4 介导的中性粒细胞反应,迁移、脱粒、白三烯生物合成。 | |||
T37256 |
12-oxo Leukotriene B4
12-oxo Leukotriene B4 |
||
Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-LO pathway. It promotes a number of leukocyte functions including aggregation, stimulation of ion fluxes, enhancement of lysosomal enzyme release, superoxide anion production, chemotaxis, and chemokinesis. 12-oxo LTB4 is an initial metabolite of LTB4 formed via the LTB4 12-hydroxydehydrogenase pathway. It is rapidly converted to 10,11-dihydro-12-oxo-LTB4, followed by reduction of the 12-oxo group to give ... | |||
T37970 |
12-epi Leukotriene B4
12-epi Leukotriene B4 |
||
Leukotriene B4 (LTB4) compounds are produced by both enzymatic and non-enzymatic processes. The products of enzymatic origin, via Leukotriene A4 (LTA4) hydrolase, are stereospecifically 12(R). Non-enzymatic hydrolysis products are 50:50 mixtures at C-12, but are almost exclusively trans at C-6. Thus, the non-enzymatic hydrolysis product of LTA4 is 6-trans-12-epi LTB4. 12-epi LTB4 is an isomer which would not be expected to occur in either non-enzymatic hydrolysis products, or in the enzymatic pr... | |||
T38157 |
Ricinelaidic Acid
|
||
Ricinelaidic acid is a 12-hydroxy fatty acid and an antagonist of leukotriene B4 (LTB4) receptors (Ki = 2 μM in porcine neutrophil membranes). It inhibits chemotaxis and calcium flux induced by LTB4 in isolated human neutrophils (IC50s = 10 and 7 μM, respectively). Ricinelaidic acid (1 mg/kg, i.v.) inhibits bronchoconstriction induced by LTB4 in rats by 46%. | |||
T15182 |
DW-1350
|
LTR | Immunology/Inflammation |
DW-1350 is an antagonist of LTB4 receptor. | |||
T37618 |
Leukotriene B4 dimethyl amide
Leukotriene B4 dimethyl amide |
||
LTB4 dimethyl amide is a moderate inhibitor of LTB4-induced degranulation of human neutrophils (Ki = 130 nM) and lysozyme release from rat PMNL. LTB4 dimethyl amide appears to be an antagonist of the LTB4 receptor on guinea pig lung membranes. | |||
T70799 | SC-50605 | ||
SC-50605 is a second-generation LTB4 receptor antagonist. | |||
T71499 |
NZ-107
|
||
NZ-107 is an LTB4, LTC4 and LTD4 antagonist. | |||
T28602 |
RO5101576
RO-5101576,RO 5101576 |
||
RO5101576 is a potent antagonist of LTB4 receptor. | |||
T37617 |
Leukotriene B3
|
||
LTB3 is the LTA hydrolase metabolite of LTA3 in the leukotriene biosynthetic pathway. LTB3 and LTB4 are equipotent in their pro-inflammatory effects. However, LTB3 is five times less potent than LTB4 in eliciting chemotaxis of human neutrophils. | |||
T71283 |
JNJ-40929837
|
||
JNJ-40929837 is an oral inhibitor of LTA4 hydrolase, which catalyzes LTB4 production. | |||
T70563 |
KC-11404
|
||
KC-11404 is an LTB4 inhibitor for the treatment of b-cell leukemias and lymphomas, potently inhibiting histamine, platelet activating factor and 5-lipoxygenase. | |||
T23895 |
WF 11605
WF11605,WF-11605 |
||
WF 11605 is an antagonist of leukotriene B4 produced by a fungus and is a specific antagonist of LTB4. | |||
T15825 | LY 178002 | Retinoid Receptor | Metabolism |
LY 178002 is an effective inhibitor of 5-lipoxygenase (5-LPO), phospholipase A2 (IC50: 0.6 μM for 5-lipoxygenase). LY 178002 also inhibits cellular production of LTB4 by human polymorphonuclear leukocytes and displays relatively weak inhibition on cycloox | |||
T37460 |
Lipoxin B4
Lipoxin B4 |
||
Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes. At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM. | |||
T37156 |
8(S),15(S)-DiHETE
|
||
8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidation by 15-LO. It causes eosinophil chemotaxis with an ED50 value of 1.5 μM but is not chemotactic for neutrophils. 8(S),15(S)-DiHETE antagonizes the hyperalgesic activity of 8(R),15(S)-DiHETE and LTB4 in the rat hind paw pain model. | |||
T24970 | 1'-Ethylascorbigen | ||
1'-Ethylascorbigen releases ascorbic acid in acidic solution results in an increase in the cells' ability to produce PGE2 & LTB4. It has been shown to inhibit the growth of experimental murine tumors. | |||
T71053 |
AHR-5333 mandelate
|
||
AHR-5333 mandelate is an anti-allergy compound which has been shown to protect against antigen-induced anaphylactic collapse and ascaris antigen-induced skin hypersensitivity. AHR-5333 mandelate has also been shown to inhibit 5-HETE, LTB4 and LTC4 synthesis. | |||
T38308 |
Lipoxin B4 methyl ester
|
||
Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4 . LXB4 is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15-HpETE by human leukocytes. At a concentration of 100 nM, LXB4 inhibits polymorphonuclear leukocyte (PMN) migration stimulated by leukotriene B4 and inhibits LTB4-induced adhesion of PMNs with an IC50 value of 0.3 nM. | |||
T37650 |
5(S),15(S)-DiHETE
|
||
5(S),15(S)-DiHETE is synthesized by 15-LO from 5(S)-HETE. It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 μM. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21504 |
γ-Linolenic Acid methyl ester
Methyl gamma-linolenate,γ-亚麻酸甲酯 |
LTR | Immunology/Inflammation |
γ-Linolenic Acid methyl ester (Methyl gamma-linolenate) 是一种弱白三烯 B4 (LTB4) 受体拮抗剂。 | |||
T7786 |
Tryptanthrin
|
DNA gyrase | DNA Damage/DNA Repair |
Tryptanthrin 是一种口服具有活性的细胞内Leukotriene (LT) biosynthesis 抑制剂。 它能够降低大鼠胸膜炎模型中的 LTB4 水平,并抑制人全血中Leukotriene 的形成 (IC50= 10 µM)。 | |||
T3868 |
Agnuside
牡荆油,穗花牡荆苷,chasteberry oil |
COX; Prostaglandin Receptor; P-gp | GPCR/G Protein; Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience |
Agnuside (chasteberry oil) 是从黄荆中分离得到的一种天然产物,可下调炎性介质PGE2和LTB4,减少细胞因子的表达,具有抗关节炎活性。 | |||
T13661 |
Docosatrienoic Acid
cis-13,16,19-docosatrienoic acid,(13Z,16Z,19Z)-13,16,19-Docosatrienoic acid |
Others | Others |
Docosatrienoic acid is a rare omega-3 fatty acid; Ki value is 5×M, which inhibits the binding of LTB4 to porcine neutrophil membrane. | |||
T4114 |
Diffractaic Acid
NSC 5901,地弗地衣酸,NSC 685595 |
Apoptosis; LTR | Apoptosis; Immunology/Inflammation |
Diffractaic Acid (NSC 685595) 是松萝的主要成分,具有止痛和解热效果,在各种疾病研究中可作为有效的促凋亡剂。 | |||
TN5164 |
trans-Hinokiresinol
|
IL Receptor; TNF; NOS; LTR | Apoptosis; Immunology/Inflammation |
Hinokiresinol is a novel inhibitor of LTB4 binding to the human neutrophils, it has antiallergic effect, it inhibits IgE-induced mouse passive cutaneous anaphylaxis reaction. Hinokiresinol (trans-hinokiresinol) and nyasol (cis-hinokiresinol) are estrogen |